Filing Details
- Accession Number:
- 0000899866-14-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-10 18:46:51
- Reporting Period:
- 2014-02-06
- Filing Date:
- 2014-02-10
- Accepted Time:
- 2014-02-10 18:46:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1564621 | B John Moriarty | Alexion Pharmaceuticals 352 Knotter Drive Cheshire CT 06410 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 Per Share | Acquisiton | 2014-02-06 | 6,068 | $0.00 | 23,268 | No | 4 | A | Direct | |
Common Stock, Par Value $.0001 Per Share | Disposition | 2014-02-07 | 1,020 | $155.55 | 22,248 | No | 4 | S | Direct | |
Common Stock, Par Value $.0001 Per Share | Disposition | 2014-02-07 | 16 | $158.56 | 22,232 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- On February 6, 2013, the reporting person was granted a performance award representing the right to receive 8,290 shares of common stock upon achievement of certain performance targets and on February 6, 2014 the Compensation Committee certified achievement of the performance targets. 1/3 of such shares vested on February 6, 2014 and 1/3 vest on each subsequent anniversary.
- This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.